Climate Change Data

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• The pharmaceutical industry faces challenges in novel molecule discovery and clinical trial execution due to small datasets.
• Securing necessary financing on acceptable terms.
• Fluctuations in interim and annual results due to various factors.
• Inaccurate sales and financial forecasts.
• Potential failure of NetraMark products to discover valuable enrichment criteria.
• Defects or disruptions in NetraMark products.
• Difficulty in maintaining existing clients and attracting new ones.
• Competition from other technology-enabled drug discovery companies.
• Lengthy and expensive pre-clinical and clinical development process with uncertain outcomes.
• Potential failures or security breaches in internal IT systems.
• Inadequate insurance coverage for substantial liabilities.
• Negative impacts from health epidemics (e.g., COVID-19).
• Unstable market and economic conditions.
• Lengthy and unpredictable regulatory approval processes.
• Lower than expected return on R&D investments.
• Smaller than anticipated market opportunities.
• Potential difficulties in managing future growth.
• Lack of analyst research coverage or unfavorable research.
• Potential adverse effects from healthcare and AI legislative reforms.
• Inability to obtain, maintain, enforce, and protect intellectual property.
• Risks associated with using open-source software.
• Potential challenges to trademarks and trade names.
• Potential intellectual property infringement lawsuits.
• Compliance with global privacy and data security requirements.
• Insufficient internal controls.

Mitigation Strategies

• Developed a novel topology-based algorithm to parse patient data and improve AI/ML methods for smaller datasets.
• Plans to improve operating cash flow through sales of NetraMark offerings and capital raises.
• Implemented work-from-home policies during the COVID-19 pandemic.
• Bolstering library of validation papers to support sales process.
• Securing The Morris Group for Quality Assurance to accelerate client contract signing.
• Attracting world-class strategic advisors with deep pharmaceutical industry experience.
• Engaging Pharma Targeting to accelerate lead generation.
• Reviewing available cybersecurity insurance coverage.

Supply Chain Management

Climate-Related Risks & Opportunities